“…Hypoleptinaemia is an independent predictor of POD [OR 0.385, CI 0.28–0.517].Yes. Sensitivity 72.2%, Specificity 91.7% | Cunningham, 2017, UK [19] | PC | 315 | > 65 | Elective hip or knee replacement | No | Yes | Serum ApoE4 allele carriage and neuropsychological tests | CAM, D1,2,3 | 76.9 yr., 65% | 74 yr., 27.1% | ApoE4 genotype is not associated with POD. | No |
Leung, 2007, USA [20] | PC | 190 | > 65 | Elective major non-cardiac | No | Yes | Serum apolipoprotein (APOE) genotype | CAM, D1–2 | 74.2 yr., NR | 72.3 yr., NR | Presence of at least one copy of APOE e4 allele is associated with increased risk of POD that persists 2 days post-op. (OR 3.64, 95% CI 1.51–8.77). | Yes |
Vasunilashorn, 2015, USA [21] | PC | 557 | > 70 | Any Elective major non-cardiac | No | Sensitivity analyses performed to test if dementia has any influence on association between ApoE and POD. | Serum Apolipoprotein E: e2, e4 carrier vs non-carrier and three category ApoE genotypes (e3e3, e3e4, e4e4, e2e2, e3e2) | CAM and validated chart review daily | | | ApoE genotype has no association with incidence, severity or duration of POD, RR for E4 = 1.0, CI 0.7–1. | No |
Torbergsen, 2015, Norway & Scotland [22] | PC | 115 | NR | Emergency hip fracture | No | Yes | Serum vitamin levels (Vitamin A, B1, B6, vitamin B12, Folic acid, vitamin C, D, K) | CAM, D1–5 | 84.8 yr., 71% | 80.6 yr., 79% | Vitamin D deficiency (< 50 nmol/L) was independent predictor of POD. (Mean Vitamin D in POD vs. no-POD, 41 vs. 52 nmolL −1 , P = 0.05). | Yes |
Scholtens, 2017, Netherlands [23] | PC | 144 | > 65 | Emergency hip fracture | No | No | Morning plasma melatonin | CAM | 85.5 yr., 75% | 82.5 yr., 69% | Morning melatonin not associated with POD ( p = 0.35) | No |
Scholtens, 2016, Netherlands [7] | PC | 60 | > 65 | Emergency hip fracture | Yes | No but confounders (age and cognitive impairment) analysed and did not show any difference in CSF melatonin levels. | CSF melatonin | Delirium Observation Screening Scale, and DSM-IV, NS | 86.4 yr., 83.3% | 83.4 yr., 66% | Pre-operative CSF melatonin did not differ between POD and no-POD groups. |
…”